2009 IPITA-IXA Joint Meeting (Venice)
|
Late-Breaking Abstract Session
16 October 2009 / 13:45 - 14:45
|
0.2 |
Pilot evaluation of GALTKO.HCD39 lungs in a xenogeneic pig lung perfusion model
Presenter: L., Burdorf, Baltimore, USA
Authors: L. Burdorf, T. Zhang, T. Stoddard, E. Welty, C. Avon, A. Laaris, X. Cheng, D. Ayares, G. Echeverri, D.K.C. Cooper, P. Cowan, A.J.F. d’Apice, E. Csizmadia, S. Robson, A. M. Azimzadeh, R. N. Pierson III
|
  |
0.3 |
First xenotransplantations of GAL KO CD55, CD59, CD39, HT transgenic pig kidneys in baboons
Presenter: S., Le Bas‑Bernardet, Nantes, France
Authors: S. Le Bas‑Bernardet, X. Tillou, N. Poirier, N. Dilek, S. Leroux, M. Chatelais, J. Devallière, B. Charreau, D. Minault, J. Hervouet, P. J. Cowan, N.M.B. NottIe , S.C. Robson, A. J.F. d’Apice, C. Galli, E. Cozzi, J.P. Soulillou, G. Blancho.
|
|
0.5 |
Donor livers expressing human CD39 are less susceptible to ischemia reperfusion injury in a mouse liver transplant model
Presenter: S., Pommey, Melbourne, Australia
Authors: S. Pommey, B. Lu, S.C. Robson, A.J. d’Apice, P.J. Cowan, K.M. Dwyer
|
|
PANCREAS ORGAN AND BETA CELL AVAILABILITY
12 October 2009 / 08:15 - 10:15
|
1.1 |
Donor preconditioning and pancreas recovery: dos and dont’s
Presenter: H., Arbogast, Munich, Germany
Authors: H. Arbogast
|
|
1.3 |
Organ allocation: Which pancreas for vascularized pancreas or isolated islet transplant
Presenter: T., Berney, Geneva, Switzerland
Authors: T. Berney
|
|
CLINICAL ISLET TRANSPLANTATION
12 October 2009 / 10:45 - 13:00
|
1.4 |
Islet transplantation for children: are we ready?
Presenter: C., Ricordi, Miami, USA
Authors: C. Ricordi
|
|
CLINICAL PANCREAS TRANSPLANTATION
12 October 2009 / 14:15 - 15:45
|
1.1 |
1,000 consecutive simultaneous pancreas~kidney transplants
Presenter: H.W., Sollinger, Madison, USA
Authors: H. W. Sollinger, J. Odorico, Y. T. Becker, G. E. Leverson, B. J. Voss, J. D. Pirsch
|
|
1.2 |
Renal retransplantation in simultaneous pancreas-kidney (SPK) recipients with functioning pancreatic allografts
Presenter: J., LaMattina, Madison, USA
Authors: J. LaMattina, J. Pirsch, Y. Becker, B. Voss, H. Sollinger, J. Odorico
|
|
1.4 |
Outcomes in > 2,000 pancreas (PX) transplants (TX) at a single institution
Presenter: D., Sutherland, Minneapolis, USA
Authors: D. Sutherland, R. Kandaswamy, T. Dunn, A. Humar, R. Gruessner, D. Radosevich, A. Gruessner, B. Bland, J. Najarian
|
|
1.5 |
Pancreas transplantation in selected type 2 diabetes mellitus recipients
Presenter: F., Vistoli, Pisa, Italy
Authors: F. Vistoli, C. Croce, M. Del Chiaro, C. Moretto, S. Signori, G. Amorese, S. Gabbriellini, V. Perrone, S. D’Imporzano, N. De Lio, P. Marchetti, F. Mosca, U. Boggi
|
|
1.6 |
Panel reactive antibodies (PRA) and antibody mediated rejection (AMR) is associated with poor outcomes following pancreas transplantation
Presenter: B., Philosophe, Baltimore, USA
Authors: B. Philosophe, B. Neuman, R. Barth, C. Drachenberg, R. Munivenkatappa
|
|
1.7 |
Simultaneous pancreas and kidney transplantation in recipients oIder than 60 years of age
Presenter: P., Girman, Prague, Czech Republic
Authors: P. Girman, K. Lipar, P. Boucek, R. Koznarova, M. Adamec, F. Saudek
|
|
1.8 |
Pancreas transplantation in elderly recipients
Presenter: F., Vistoli, Pisa, Italy
Authors: F. Vistoli, G. Amorese, S. Signori, M. Del Chiaro, C. Croce, C. Moretto, S. Gabbriellini, N. De Lio, S. D’Imporzano, V. Perrone, P. Marchetti, F. Mosca, U. Boggi
|
|
1.9 |
Expanded criteria donors in pancreas transplantation: the Oxford experience
Presenter: A. S. R., Muthusamy, Oxford, UK
Authors: A. S. R. Muthusamy, J. G. Brockmann, S. Sinha, A. C. Vaidya , P. J. Friend
|
|
13 September 2010 / 18:05 - 18:20
|
1.3 |
IPITA General Assembly Meeting
Presenter: IPITA, General Assembly Meeting, ,
Authors:
|
|
IMMUNOLOGICAL CONCEPTS AND DIAGNOSTIC TOOLS
14 October 2009 / 08:00 - 10:30
|
1.1 |
The hyperimmunized patient
Presenter: J., Grinyó, Barcelona, Spain
Authors: J. Grinyó
|
|
1.5 |
New diagnostic tools
Presenter: A., Zachary, Baltimore, USA
Authors: A. Zachary
|
|
ISLET XENOTRANSPLANTATION 1 AND ENCAPSULATION
15 October 2009 / 11:00 - 13:15
|
1.3 |
Expression of human CD39 on mouse islets protects against chemically induced diabetes
Presenter: J., Chia, Victoria, Australia
Authors: J. Chia, S. Robson, T. Mysore, P. Cowan, A. d’Apice, K. Dwyer
|
|
1.4 |
A Scoring to evaluate the function of islet grafts in a primate preclinical model
Presenter: Y., Igarashi, Louvain, Belgium
Authors: D. Dufrane, R.M. Goebbels, Y. Igarashi, W. D’hoore, P. Gianello
|
|
1.5 |
The evidences of induced autoimmune diabetes in primates: establishment of a preclinical large animal model of T1DM
Presenter: Y., Lu, Sichuan, China
Authors: Y. Lu, L. Wei, Y. Chen, X. Jin, B. Tian, G. Mai, L. Zeng, S. He, Y. Ren, C. Qiao, G. Yang, L. Wang, H. Li, J. Cheng, S. Deng
|
|
